What Led The Verona Pharma (VRNA) Stock To Increase 34% Pre-Market?
After releasing topline statistics, shares of Verona Pharma plc (Nasdaq: VRNA) were up 34.69% at $18.17 at the time of our last check in pre-market trading. What summary data were supplied by VRNA? Positive findings from the Phase 3 ENHANCE-1 study testing nebulized ensifentrine for the treatment modality of chronic obstructive pulmonary disease (COPD) were […]